Callitas Therapeutics
β Verified ManufacturerAbout
Callitas Therapeutics Inc is a specialized pharmaceutical company based in Newport, Kentucky, focused on developing innovative medical technologies for obesity management, weight control, and female health applications. Located at 187 Pavilion Parkway Suite 200, the company operates as a clinical-stage biopharmaceutical firm dedicated to addressing critical healthcare needs through advanced therapeutic solutions. The company has established expertise in developing products for monitoring and treating obesity, diabetes, and gastroenterological conditions. Their product portfolio includes ToConceive, a clinically proven fertility-enhancing moisturizer designed to increase natural conception lubrication, and reformulated Orlistat for weight management applications. Additionally, Callitas develops Extrinsa, a topical treatment for women experiencing orgasm and arousal difficulties, featuring non-hormonal and non-systemic properties. Formerly operating as M Pharmaceutical USA, Callitas Therapeutics represents the evolution of pharmaceutical innovation in the Kentucky region. The company maintains a strong focus on developing technologies that serve underaddressed therapeutic areas, particularly in metabolic health and female wellness sectors. Their clinical-stage development approach ensures rigorous testing and validation of therapeutic products before market introduction. Through strategic research and development initiatives, Callitas Therapeutics continues to advance pharmaceutical manufacturing capabilities while maintaining commitment to quality standards and regulatory compliance essential in the pharmaceutical industry.